Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Biote Q3 EPS $0.22 Beats $0.07 Estimate, Sales $47.956M Beat $47.757M Estimate

Author: Benzinga Newsdesk | November 05, 2025 04:19pm
Biote (NASDAQ:BTMD) reported quarterly earnings of $0.22 per share which beat the analyst consensus estimate of $0.07 by 214.29 percent. This is a 33.33 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $47.956 million which beat the analyst consensus estimate of $47.757 million by 0.42 percent. This is a 6.67 percent decrease over sales of $51.384 million the same period last year.

Posted In: BTMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist